Dezhi Kong

发表

OTT_A_270398 11111..11124

Shicheng Li, Xiao Sun, W. Jiao, 2020 .

Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors

Wei Zhang, X. Ren, Taojing Wu, 2022, Frontiers in Pharmacology.

Movement disorder caused by FRRS1L deficiency may be associated with morphological and functional disorders in Purkinje cells

Zhanfeng Jia, Wei Zhang, Shu-feng Liu, 2022, Brain Research Bulletin.

Essential Oils: Chemical Constituents, Potential Neuropharmacological Effects and Aromatherapy - A Review

Yutong Zhao, Haonan Liu, Dezhi Kong, 2022, Pharmacological Research - Modern Chinese Medicine.

Jujuboside B inhibits febrile seizure by modulating AMPA receptor activity.

Jie Hao, Qingzhong Jia, Chang-zheng Dong, 2022, Journal of ethnopharmacology.

Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non‐small cell lung cancer

Shicheng Li, Xiao Sun, Shuncheng Miao, 2019, Cancer medicine.

Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression.

Jianxun Wang, Wanpeng Yu, Xiao Sun, 2019, Translational lung cancer research.

Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Shicheng Li, Xiao Sun, W. Jiao, 2020, OncoTargets and therapy.

Exploring the therapeutic potential of cannabidiol for sleep deprivation-induced hyperalgesia

Dezhi Kong, Wanjun Bai, Zuxiao Yang, 2024, Neuropharmacology.